Cargando…
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
Hepatitis B virus (HBV) chronically infects over 250 million people worldwide and causes nearly 1 million deaths per year due to cirrhosis and liver cancer. Approved treatments for chronic infection include injectable type-I interferons and nucleos(t)ide reverse transcriptase inhibitors. A small min...
Autores principales: | Novotny, Laura A., Evans, John Grayson, Su, Lishan, Guo, Haitao, Meissner, Eric G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230240/ https://www.ncbi.nlm.nih.gov/pubmed/34207487 http://dx.doi.org/10.3390/v13061090 |
Ejemplares similares
-
Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling
por: Evans, John Grayson, et al.
Publicado: (2023) -
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
por: Ansari, M Azim, et al.
Publicado: (2019) -
The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection
por: Heidari, Zahra, et al.
Publicado: (2016) -
Multi-ancestry Fine Mapping of Interferon Lambda and the Outcome of Acute Hepatitis C Virus Infection
por: Vergara, Candelaria, et al.
Publicado: (2020) -
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
por: Chaturvedi, Nimisha, et al.
Publicado: (2019)